All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. What are the recommended clinical assessment and screening tests during pregnancy?

    KCE Reports 248 (2015)

    https://kce.fgov.be/en/what-are-the-recommended-clinical-assessment-and-screening-tests-during-pregnancy

  2. Non-invasive markers of subclinical atherosclerosis for predicting a primary cardiovascular event: a rapid systematic review

    KCE Reports 244 (2015)

    https://kce.fgov.be/en/non-invasive-markers-of-subclinical-atherosclerosis-for-predicting-a-primary-cardiovascular-event-a

  3. Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2

    KCE Reports 243 (2015)

    https://kce.fgov.be/en/oncogenetic-testing-diagnosis-and-follow-up-in-birt-hogg-dub%C3%A9-syndrome-familial-atypical-multiple

  4. Oncogenetic testing for persons with hereditary endocrine cancer syndromes

    KCE Reports 242 (2015)

    https://kce.fgov.be/en/oncogenetic-testing-for-persons-with-hereditary-endocrine-cancer-syndromes
  5. CP241

    Cardiovascular pre-participation screening in young athletes

    KCE Reports 241 (2015) About 1 million young Belgians (14-34) are member of a sportsclub, and in addition, many others are practicing a sport outside the structure of a sport organization. As we all know, sport is very good for your health. But, unfortunately, but luckily very seldom, it can lead to a sudden death due to cardiac failure. The authorities already have made a lot of effort to limit the risk for sporters. But can we avoid this kind of shocking events by submitting young sporters, without heart complaints, to a systematic heart examination?

    https://kce.fgov.be/en/cardiovascular-pre-participation-screening-in-young-athletes

  6. Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening

    KCE Reports 238 (2015)

    https://kce.fgov.be/en/cervical-cancer-screening-program-and-human-papillomavirus-hpv-testing-part-ii-update-on-hpv-primary

  7. Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li Fraumeni syndrome and Cowden syndrome

    KCE Reports 236 (2015)

    https://kce.fgov.be/en/oncogenetic-testing-and-follow-up-for-women-with-familial-breastovarian-cancer-li-fraumeni-syndrome

  8. A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

    KCE Reports 231 (2014)

    https://kce.fgov.be/en/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effectiveness-study

  9. Prevention of preterm birth in women at risk: selected topics

    KCE Reports 228 (2014)

    https://kce.fgov.be/en/prevention-of-preterm-birth-in-women-at-risk-selected-topics

  10. A decision aid for an informed choice when patient asks for PSA screening

    KCE Reports 224 (2014)

    https://kce.fgov.be/en/a-decision-aid-for-an-informed-choice-when-patient-asks-for-psa-screening

  11. Oncogenetic testing for Lynch syndrome and familial adenomatous polyposis

    KCE Reports 220 (2014)

    https://kce.fgov.be/en/oncogenetic-testing-for-lynch-syndrome-and-familial-adenomatous-polyposis

  12. Informed choice on breast cancer screening: messages to support informed decision

    KCE Reports 216 (2014)

    https://kce.fgov.be/en/informed-choice-on-breast-cancer-screening-messages-to-support-informed-decision

  13. Seasonal influenza vaccination: prioritizing children or other target groups? - Part II

    KCE Reports 204 (2013)

    https://kce.fgov.be/en/seasonal-influenza-vaccination-prioritizing-children-or-other-target-groups-part-ii

  14. [Vaccine safety surveillance in Belgium : place and limits of a background rate approach]

    KCE Reports 188 (2012)

    https://kce.fgov.be/en/vaccine-safety-surveillance-in-belgium-place-and-limits-of-a-background-rate-approach

  15. [Breast cancer screening amongst women aged 70-74 years of age]

    KCE Reports 176 (2012)

    https://kce.fgov.be/en/breast-cancer-screening-amongst-women-aged-70-74-years-of-age
  16. Hepatitis C: Screening en Preventie

    [Hepatitis C: Screening and Prevention]

    KCE Reports 173 (2012)

    https://kce.fgov.be/en/hepatitis-c-screening-and-prevention

  17. [Identifying women at risk for breast cancer/technical methods for breast cancer screening]

    KCE Reports 172 (2012)

    https://kce.fgov.be/en/identifying-women-at-risk-for-breast-cancertechnical-methods-for-breast-cancer-screening

  18. Seasonal influenza vaccination: priority target groups – Part I

    KCE Reports 162 (2011)

    https://kce.fgov.be/en/seasonal-influenza-vaccination-priority-target-groups-%E2%80%93-part-i

  19. Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood

    KCE Reports 155 (2011)

    https://kce.fgov.be/en/cost-effectiveness-of-10-and-13-valent-pneumococcal-conjugate-vaccines-in-childhood

  20. [Cost-utility of Vaccination against Chickenpox in Children and against Herpes Zoster in Elderly in Belgium]

    KCE Reports 151 (2010)

    https://kce.fgov.be/en/cost-utility-of-vaccination-against-chickenpox-in-children-and-against-herpes-zoster-in-elderly-in

Pages